What is IPAX?
IPAX, Inc. operates as a comprehensive contract manufacturer and packager for medical devices. The company is instrumental in assisting emerging businesses in bringing their innovative products to market efficiently and with reduced capital outlay. IPAX provides tailored finished medical device manufacturing and packaging services, capable of accommodating both low-volume, rapid production needs and high-volume, large-scale manufacturing. Their operational ethos prioritizes superior customer service, swift response times, and punctual delivery, ensuring a seamless experience for their clientele. IPAX's commitment to quality is further validated by its FDA Registered and ISO 13485-2016 certified facilities, highlighting a dedication to both stringent quality standards and ongoing innovation within the medical device industry.
How much funding has IPAX raised?
IPAX has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in IPAX
PPP
Public-Private Partnership
What's next for IPAX?
With its recent strategic investment and substantial total funding, IPAX is well-positioned for continued expansion and enhancement of its service offerings. The company's focus on quality, efficiency, and client support, coupled with its robust manufacturing capabilities, suggests a strategic direction towards scaling operations and potentially broadening its market reach. Future developments may include investments in advanced manufacturing technologies, further certifications, or strategic partnerships to solidify its role as a key player in the medical device supply chain. The substantial capital infusion indicates confidence from investors in IPAX's business model and its capacity to meet the evolving demands of the medical device market.
See full IPAX company page
